NSC |
Compound |
Enrichment |
Correlation |
NSC 719468 |
Null |
0.00770426557728506 |
0.26367512 |
NSC 73735 |
B 3845 |
0.00770426557728506 |
0.45090861 |
NSC 757113 |
METHOTREXATE(+/-) |
0.00770426557728506 |
0.24823986 |
NSC 761821 |
Null |
0.00770426557728506 |
-0.13403261 |
NSC 126228 |
Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.00803384002766641 |
0.42400203 |
NSC 303861 |
L-Cysteine analog |
0.00803384002766641 |
0.39845186 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.00803384002766641 |
0.41888199 |
NSC 372155 |
2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- |
0.00803384002766641 |
0.42265478 |
NSC 604976 |
Verrucarin A, 7'-deoxo-2'-deoxy-2',3'-epoxy-8',9',10',11'- tetrahydro-4',8-dihydroxy-7'-(1-hydroxyethyl)- |
0.00803384002766641 |
0.55092562 |
NSC 614887 |
Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) |
0.00803384002766641 |
0.39055777 |